Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
about
Structural basis for antagonism and resistance of bicalutamide in prostate cancerPreclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraceptionSelective androgen receptor modulators in preclinical and clinical developmentCharacterization of the in vitro metabolism of selective androgen receptor modulator using human, rat, and dog liver enzyme preparationsSelective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized ratsDiscovery and therapeutic promise of selective androgen receptor modulatorsPharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligandsChemistry and structural biology of androgen receptorCrystal Structure of the T877A Human Androgen Receptor Ligand-binding Domain Complexed to Cyproterone Acetate Provides Insight for Ligand-induced Conformational Changes and Structure-based Drug DesignEffect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulatorsTriclocarban enhances testosterone action: a new type of endocrine disruptor?Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugsSelective androgen receptor modulators as function promoting therapies.Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.Structural basis for computational screening of non-steroidal androgen receptor ligands.Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.Development of selective androgen receptor modulators (SARMs).Region-specific mechanisms for testosterone-induced Fos in hamster brain.Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products.Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic characteristics of a propanamide in preclinical studyDrug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and agingStructural basis for accommodation of nonsteroidal ligands in the androgen receptorFavorable effects of weak acids on negative-ion electrospray ionization mass spectrometryIn vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ringTestosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.Pharmacotherapy for prostate cancer, with emphasis on hormonal treatments.Emerging drugs for hypogonadism.The latest options and future agents for treating male hypogonadism.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Vitamin D receptor ligands: the impact of crystal structures.A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.QSAR models for anti-androgenic effect--a preliminary study.Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.Recent discoveries and developments of androgen receptor based therapy for prostate cancer
P2860
Q24523708-236F585C-FB15-4136-9146-548C5924D68BQ24645334-3008309D-D49B-4568-B9C4-9D7C5CAB7AB6Q24645579-A423383B-ACDA-40EA-89ED-97608B547394Q24676629-23E1BEE8-95F3-4F1D-AC85-52981522F09AQ24676655-8ED3489C-490C-450D-B95A-DB22A5ABBFB7Q24680356-F9CFAFC1-6B44-454C-A7C8-3C29E990FBB6Q24680373-27326F4C-E03C-48B5-88C8-B7330FF3C24AQ24685498-05768925-7170-46AB-B260-F8210A2E7DFAQ27643866-BCA82DF1-FCAB-41BB-AC8A-7212E59DDFE8Q27652258-B540F7FC-B9FC-48E5-BF1A-52AC041A7A95Q28259283-CE059DC1-505D-4012-81E7-2B461F674D51Q33289718-3FBC9D57-7A0D-403D-9B20-E7EA43ED66D5Q34007493-DC75AD1D-2874-46A2-8534-69026EB1FE55Q34035236-039C9A45-F72B-4ED7-828B-BF4C90AAFE27Q34289773-6056A55A-6870-496B-93A9-58F82BE0856AQ34340804-A40DB894-1D6E-4F45-9675-D90014AF2B80Q34558010-C6012EFB-6C2A-4B9B-82BB-333D539FF0F4Q35762334-70F40D91-8A37-444D-B66E-2673559F1FF1Q35995843-AD4EF800-5046-4A3A-9C5E-4502E45E0880Q36087721-C08B02D0-D668-4D52-ABFB-1A8956067389Q36130944-2F8447FF-D50C-48E6-A2E6-492D89BD9DF3Q36130953-2B243EDF-C4A4-4E9D-A748-8C14826180A9Q36184328-D31929FB-BDE4-4715-AAC4-16DC2B444DC9Q36237781-73D0E89E-E38C-4188-B159-67BF947BAACFQ36271731-3F639A39-E788-42E1-9522-57E22C7CC935Q36447393-AF9941B3-3CD0-4F69-B426-4D508767E7B2Q36573874-7205492B-4EBF-46EB-8378-94F1937B9A28Q36634275-C2578936-698B-4046-BB00-2A5C07A6415AQ37000744-45C0F11F-9C2F-4125-956D-DAD0C612B1A7Q37236103-ED71708B-D212-40D4-8003-CF1783D8F719Q37997100-1F1D3B5A-4DE6-48E9-86FF-3876F9C5A0DAQ40197853-DA221BA2-8920-40E5-AB0D-03360A5DA41DQ51769183-73B9C1CC-2BA8-49C1-AE3B-DCBCB0745495Q52677958-2B0F2303-046D-4DF6-BBA8-9955F55222F3Q56621622-720922F4-F4A4-4829-A33D-81A813FC5F5A
P2860
Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Key structural features of non ...... tion of the androgen receptor.
@ast
Key structural features of non ...... tion of the androgen receptor.
@en
Key structural features of non ...... tion of the androgen receptor.
@nl
type
label
Key structural features of non ...... tion of the androgen receptor.
@ast
Key structural features of non ...... tion of the androgen receptor.
@en
Key structural features of non ...... tion of the androgen receptor.
@nl
prefLabel
Key structural features of non ...... tion of the androgen receptor.
@ast
Key structural features of non ...... tion of the androgen receptor.
@en
Key structural features of non ...... tion of the androgen receptor.
@nl
P2093
P356
P1476
Key structural features of non ...... ation of the androgen receptor
@en
P2093
Craig Marhefka
Donghua Yin
Duane D Miller
Leonid Kirkovsky
Minoli A Perera
Nina Stourman
Seoung Soo Hong
P304
P356
10.1124/MOL.63.1.211
P577
2003-01-01T00:00:00Z